InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: Vlady 1 post# 231311

Tuesday, 06/19/2018 1:10:52 PM

Tuesday, June 19, 2018 1:10:52 PM

Post# of 403222
Vlady. Educated guess. MGMT is 100% behind "business development" right now. That means deals and multiple deals. This is a small company and many forget that.....but they are super small and for what they have accomplished it may seem like a full staff and huge biotech but this is super small. They have dedicated resources allocated to each phase and pipeline and the main focus has been entertaining CDA's and weighing options.

The option of hiding data because of failure is impossible. Literally a zero percent chance on that. Leo has openly admitted that the trial is still BLIND. They have no data as of last week. They will get the data lock notification and then notify us. From there they will dice the data and present it to shareholders. From the Phase 2a and from pre-clinical data I think we have an exceptional chance for STELLAR data and that has not changed with this delay.

I just feel that negotiations and first license deal is the priority now. Money possibly owed to the CRO for P trial may have went to other areas - manufacturing etc...for B prior to P data. Leo said he used some low financing for a lump sum that was needed "NOW" and thats what they had to do and I hope to see in the near future that decision pays off in multiples of a 100.

This is a toxic board and leads imagination furthest from the truth. MGMT will let their actions speak when the time is right. The quiet is welcoming and the share price is taking a hit but what is to come will hopefully allow us to never look back.
JMO
Daubs.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News